Show simple item record

dc.contributor.authorVallance, P.
dc.contributor.authorBush, H.D.
dc.contributor.authorMok, B.J.
dc.contributor.authorHurtado-Guerrero, R.
dc.contributor.authorGill, H.
dc.contributor.authorRossiter, S.
dc.contributor.authorWilden, J.D.
dc.contributor.authorCaddick, S.
dc.date.accessioned2007-09-18T13:20:31Z
dc.date.available2007-09-18T13:20:31Z
dc.date.issued2005
dc.identifier.citationVallance , P , Bush , H D , Mok , B J , Hurtado-Guerrero , R , Gill , H , Rossiter , S , Wilden , J D & Caddick , S 2005 , ' Inhibition of dimethylarginine dimethylaminohydrolase (DDAH) and arginine deiminase (ADI) by pentafluorophenyl (PFP) sulfonates ' , Chemical Communications , vol. 44 , pp. 5563-5565 .
dc.identifier.issn1359-7345
dc.identifier.otherdspace: 2299/638
dc.identifier.otherORCID: /0000-0003-3822-0028/work/142009582
dc.identifier.urihttp://hdl.handle.net/2299/638
dc.format.extent79114
dc.language.isoeng
dc.relation.ispartofChemical Communications
dc.subjectPharmacology and pharmacy
dc.titleInhibition of dimethylarginine dimethylaminohydrolase (DDAH) and arginine deiminase (ADI) by pentafluorophenyl (PFP) sulfonatesen
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionCentre for Research in Mechanisms of Disease and Drug Discovery
dc.contributor.institutionNatural Product Chemistry and Drug Design
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record